Formustine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Formustine, covering 2022-06-02 to 2022-06-02. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective Clinical Study of BTK Inhibitor, PD-1 and Formustine in the First-line Treatment of Primary Central Nervous System Lymphoma [Phase 1, Phase 2]